Vaccine policy decisions: tension between science, cost-effectiveness and consensus?
Zimmerman
R K
RK
Jackson
R E
RE
D000367:Age Factors; D002487:Centers for Disease Control and Prevention, U.S.; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine; D006291:Health Policy; D006801:Humans; D017589:Immunization Programs / Q000592:standards*; D007115:Immunization Schedule; D015994:Incidence; D011008:Pneumococcal Infections / Q000453:epidemiology / Q000208:ethnology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000191:economics* / Q000592:standards*; D011050:Policy Making; D017410:Practice Guidelines as Topic; D012586:Science; D014481:United States / Q000453:epidemiology; D018074:Vaccines, Conjugate / Q000191:economics / Q000592:standards
D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate